Drug developer Inspire Pharmaceuticals Inc . ISPH.O tumbled $ 2.17 , or 13.4 percent , to $ 13.98 .
Inspire Pharmaceuticals stock price dropped 13.4% after the company announced a delay in the FDA review of its drug application.